Mackay Shields LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Mackay Shields LLC's EW Position: Q2 2022 in Review
Mackay Shields LLC sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 89,508 shares — an estimated $10.5M sold.
Mackay Shields LLC first reported a position in EW in Q1 2018 and held it in 17 quarters. The position peaked at $12.1M in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.
- Mackay Shields LLC reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
- Mackay Shields LLC sold 89,508 Edwards Lifesciences shares in Q2 2022, an estimated $10.5M.
- Mackay Shields LLC first reported a position in Edwards Lifesciences in Q1 2018 and held it in 17 quarters.
- Mackay Shields LLC's Edwards Lifesciences position peaked at $12.1M in Q4 2021.
- 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.
Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.